CD95 ligand induces motility and invasiveness of apoptosis-resistant tumor cells. - Wikidata - wikimedia - TriplyDB

CD95 ligand induces motility and invasiveness of apoptosis-resistant tumor cells.

CD95 ligand induces motility and invasiveness of apoptosis-resistant tumor cells.

http://www.wikidata.org/entity/Q39959143

about

Identification of SNF1/AMP kinase-related kinase as an NF-kappaB-regulated anti-apoptotic kinase involved in CD95-induced motility and invasiveness The role of receptor internalization in CD95 signaling.Palmitoylation of CD95 facilitates formation of SDS-stable receptor aggregates that initiate apoptosis signaling CD95 promotes tumour growth The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2 Astrocyte reactivity to Fas activation is attenuated in TIMP-1 deficient mice, an in vitro study.Death receptor-ligand systems in cancer, cell death, and inflammation The role of CD95 and CD95 ligand in cancer Mitochondria in traumatic brain injury and mitochondrial-targeted multipotential therapeutic strategies The naturally processed CD95L elicits a c-yes/calcium/PI3K-driven cell migration pathway CD95 maintains stem cell-like and non-classical EMT programs in primary human glioblastoma cells NF-κB directly regulates Fas transcription to modulate Fas-mediated apoptosis and tumor suppression The role of MMP7 and its cross-talk with the FAS/FASL system during the acquisition of chemoresistance to oxaliplatin Palmitoylation is required for efficient Fas cell death signaling A Fas Ligand (FasL)-Fused Humanized Antibody Against Tumor-Associated Glycoprotein 72 Selectively Exhibits the Cytotoxic Effect Against Oral Cancer Cells with a Low FasL/Fas Ratio.Bax-dependent regulation of Bak by voltage-dependent anion channel 2.The marine lipopeptide somocystinamide A triggers apoptosis via caspase 8.Many checkpoints on the road to cell death: regulation of Fas-FasL interactions and Fas signaling in peripheral immune responses.Blockade of Fas signaling in breast cancer cells suppresses tumor growth and metastasis via disruption of Fas signaling-initiated cancer-related inflammation.CD95/Fas Increases Stemness in Cancer Cells by Inducing a STAT1-Dependent Type I Interferon Response.Death receptor signals to mitochondria.Induction of apoptosis and activation of NF-kappaB by CD95 require different signalling thresholds.Autoimmune lymphoproliferative syndrome: molecular basis of disease and clinical phenotype.Targeting Fas in osteoresorptive disorders.Fas signaling promotes chemoresistance in gastrointestinal cancer by up-regulating P-glycoprotein.FAPP2 gene downregulation increases tumor cell sensitivity to Fas-induced apoptosis Fas Signaling Promotes Gastric Cancer Metastasis through STAT3-Dependent Upregulation of Fascin The role of c-FLIP splice variants in urothelial tumours.Fas ligand enhances malignant behavior of tumor cells through interaction with Met, hepatocyte growth factor receptor, in lipid rafts.CD95 promotes metastatic spread via Sck in pancreatic ductal adenocarcinoma.Regulation of let-7 and its target oncogenes (Review)The actin cytoskeleton as a sensor and mediator of apoptosis Study of the CD95-Mediated Non-apoptotic Signaling Pathway: PI3K.Targeting the Fas/Fas ligand pathway in cancer.Activated cytotoxic lymphocytes promote tumor progression by increasing the ability of 3LL tumor cells to mediate MDSC chemoattraction via Fas signaling.Estrous cycle-dependent changes of Fas expression in the bovine corpus luteum: influence of keratin 8/18 intermediate filaments and cytokines Prostaglandin E2 stimulates Fas ligand expression via the EP1 receptor in colon cancer cells.microRNAs and death receptors.Cells surviving fractional killing by TRAIL exhibit transient but sustainable resistance and inflammatory phenotypes.Caspase 8 promotes peripheral localization and activation of Rab5.

P2860

Q24302467-3B537C27-AE4C-426B-9129-A8AF39172492 Q24305510-51ADCAFA-32D1-4105-926E-13BC6A24A8DD Q24328893-C47284E0-EC3E-473B-8E21-04004A237FFE Q24602589-445A2784-23ED-413C-85A0-F46FE028DD27 Q24646996-B210BECF-3438-4FF5-83EF-FCCAE7FF9FE2 Q25255834-846ABAD7-E7BF-4B03-BD12-B1F437DA3FAA Q26865568-0381C9DC-9C5C-4072-BC12-09F898CDC079 Q26995847-6B18DB23-A400-4D54-BC08-0C827E8D1393 Q27024426-7FB7FE67-6E07-48D7-AA9D-DBBC20851972 Q27321306-C41AE7A9-5A34-4129-BB95-077E9F679B49 Q27329081-B9217C86-0FC3-47E2-8B14-0671276660F8 Q28268202-2513E8F8-5FA9-488E-9D21-57EDEFD97E69 Q28474925-CF4DDF44-5E8A-4804-A780-BA9D6CFBBA02 Q28591409-46599366-6236-4598-9D39-DFB82EF204F0 Q30252954-916FCE26-9613-4B72-A49D-DF56753C69CF Q33212700-CD0C348A-756C-4CB8-B58E-CEC51B15D21F Q33319367-34C2BD8E-9345-406F-9DB4-F0C0EBD511C7 Q33672489-832907FD-6589-4088-90B6-78998AF8ADA6 Q33676412-45ACF467-1351-4DA7-830C-0487C00A1AC4 Q33809161-A6004D5A-2FA6-46A7-AB79-9CE9EABAC4D3 Q34139596-BA311A32-B830-434C-9E4F-E18C06B32782 Q34166328-B64F5036-683E-4D9D-A05D-DAF2042648F3 Q34513178-46F9D5A9-B8E3-4048-9E2C-04C73BAEA858 Q34561691-9C9CA4E4-E6A6-4BAB-B2C9-36173A438038 Q34786557-BE892458-B97E-4A3A-AF20-C503D19DB7D8 Q34973761-34BB4B90-17EE-483F-A03A-D939371263D0 Q35620662-7889F7B6-6F5E-4855-B667-3FE844B5A4DA Q35657114-7619846F-689B-4C2B-8FE7-3B9AC260ED5B Q36016981-963EFB0A-1A1C-42CE-A550-507A981C4397 Q36067765-D044B229-08D6-4981-8701-B690A5F334C7 Q36076000-BD519C7E-BED1-404E-ACF0-0CAB1B4DF32F Q36149204-B5496BB4-741D-41B4-895F-FA2F54364A1C Q36247016-869E093C-C62A-469B-AAC7-44BFA1B90D74 Q36268329-727E8A6F-25C6-44D8-B59C-FD4F115FC82E Q36302820-B592F18C-4EBE-4E99-8A63-FCE0BB6E47DF Q36597102-9603B9FD-3A02-4763-9ECB-F11EADBC6721 Q36858103-37AEF8B4-05D5-47DB-8530-D23A3651AB4F Q36983175-5E1991FB-CDDB-4D56-81EF-5AF3FDDCF897 Q37003894-A4A6997E-B42C-450F-8101-55F1C87BAC38 Q37021567-9D7B3CF6-ED3A-4D5C-B059-862D73980D99

P2860

CD95 ligand induces motility and invasiveness of apoptosis-resistant tumor cells.

http://www.wikidata.org/entity/Q39959143

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年学术文章

@wuu

2004年学术文章

@zh-cn

2004年学术文章

@zh-hans

2004年学术文章

@zh-my

2004年学术文章

@zh-sg

2004年學術文章

@yue

2004年學術文章

@zh

2004年學術文章

@zh-hant

name

CD95 ligand induces motility and invasiveness of apoptosis-resistant tumor cells.

@en

CD95 ligand induces motility and invasiveness of apoptosis-resistant tumor cells.

@nl

type

label

CD95 ligand induces motility and invasiveness of apoptosis-resistant tumor cells.

@en

CD95 ligand induces motility and invasiveness of apoptosis-resistant tumor cells.

@nl

prefLabel

CD95 ligand induces motility and invasiveness of apoptosis-resistant tumor cells.

@en

CD95 ligand induces motility and invasiveness of apoptosis-resistant tumor cells.

@nl

P1433

Q39959143-2EC9DBA1-CF65-491B-A549-C19F543AF63E

P1476

Q39959143-F9603EDE-BB4D-4519-AAB8-FEBC49824938

P2093

Q39959143-2C62B16C-208F-48AC-B6DD-03B6E104F59E

Q39959143-B247D6E0-732D-4110-B709-8134F9A5A4A7

Q39959143-D95B23CA-793C-4E27-9561-5F904B844ABA

P2860

Q39959143-00E9FBB4-991D-44D3-B536-45F21AC589A3

Q39959143-0E5469D0-2CFA-424D-896C-EED33BC51AA3

Q39959143-0E915402-6553-40FC-B40D-80ACF2DCC784

Q39959143-0F98838C-85B1-42E2-AD77-B7FA15ECEBBA

Q39959143-101C1C6A-A11C-41DB-84E2-B9FCDBD8B28B

Q39959143-10F0CA25-08BE-4E78-95D7-E86496D4C941

Q39959143-17D3EA8B-138F-42E3-B51D-764F84297496

Q39959143-17FFEAA5-F912-45E2-AA44-055E5D8EFB03

Q39959143-19D368A5-F2C4-4F4A-832B-3FF31D366614

Q39959143-1A7198FD-D2CD-4B4F-9392-DF927D02941D

P304

Q39959143-92E6EE53-296B-4E51-9430-C440BDB7DBF3

P31

Q39959143-439FFCEA-968B-4216-A35E-5C95A30887E7

P356

Q39959143-722DE8AF-ED5C-4378-B8DE-AD3EEFEC8CD2

P407

Q39959143-4F3A63A8-D351-4C56-BD4C-0ACA6F86B461

P433

Q39959143-5BF239D6-6E44-4CE8-A73A-7A56922BE4A0

P478

Q39959143-91713FBE-829D-4D7F-B5C0-53AE6721140C

P50

Q39959143-3EA929F3-E5A5-4BED-B673-E8063F8FB988

Q39959143-6B31B88D-FBB1-4FDE-9D1A-72CFEE79714D

Q39959143-D1842985-60D1-4636-A7EB-35008A0BA77F

P577

Q39959143-AD6D334C-CAA0-4856-BD25-629E2E31BE89

P5875

Q39959143-2A589DB0-D3A6-44A9-AF27-FDBD31493A8B

P698

Q39959143-37D10FBB-C1CF-4615-AA1E-FA6A8EA39E58

P921

Q39959143-D41E07B3-FA66-4B94-88DF-5D7D3367C5AF

P932

Q39959143-7C1A9572-E1F5-49E0-8AFC-709F1A8509F7

P356

SJ.EMBOJ.7600325

P1433

The EMBO Journal

P1476

CD95 ligand induces motility and invasiveness of apoptosis-resistant tumor cells.

@en

P2093

Bryan C Barnhart

http://www.w3.org/2001/XMLSchema#string

Eric Pietras

http://www.w3.org/2001/XMLSchema#string

Guido Franzoso

http://www.w3.org/2001/XMLSchema#string

P2860

IKK-1 and IKK-2: cytokine-activated IkappaB kinases essential for NF-kappaB activation

A novel complex between the p65 subunit of NF-kappa B and c-Rel binds to a DNA element involved in the phorbol ester induction of the human urokinase gene

Selective inhibition of NF-kappaB activation by a peptide that blocks the interaction of NEMO with the IkappaB kinase complex

Inactivation of caspase-8 on mitochondria of Bcl-xL-expressing MCF7-Fas cells: role for the bifunctional apoptosis regulator protein

The death domain kinase RIP mediates the TNF-induced NF-kappaB signal

Two CD95 (APO-1/Fas) signaling pathways

The chemotherapeutic drug 5-fluorouracil induces apoptosis in mouse thymocytes in vivo via activation of the CD95(APO-1/Fas) system.

The use of TNF family ligands and receptors and agents which modify their interaction as therapeutic agents.

Urokinase plasminogen activator: a prognostic marker in multiple types of cancer.

Cytotoxic drugs and the CD95 pathway.

P304

3175-3185

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.EMBOJ.7600325

http://www.w3.org/2001/XMLSchema#string

P407

P433

15

http://www.w3.org/2001/XMLSchema#string

P478

23

http://www.w3.org/2001/XMLSchema#string

P50

Patrick Legembre

Marcus E. Peter

Concetta Bubici

P577

2004-07-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8437986

http://www.w3.org/2001/XMLSchema#string

P698

15272306

http://www.w3.org/2001/XMLSchema#string

P921

apoptotic process

P932

514938

http://www.w3.org/2001/XMLSchema#string